Abeona Therapeutics (ABEO) Change in Accured Expenses (2011 - 2026)

Abeona Therapeutics' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$7.3 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 207.61% year-over-year to -$7.3 million; the TTM figure through Mar 2026 stood at -$5.0 million (down 713.19% YoY), while the FY2025 annual figure was -$85000.0, down 105.64% from the prior year.
• Change in Accured Expenses was -$7.3 million for Q1 2026 at Abeona Therapeutics, down from -$2.4 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $4.8 million in Q4 2022 to a low of -$7.3 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged -$399250.0 across 5 years, with a median of -$42500.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses plunged 169100.0% in 2024, then surged 1367.09% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $4.8 million in 2022, then slumped by 104.1% to -$198000.0 in 2023, then jumped by 962.12% to $1.7 million in 2024, then slumped by 239.84% to -$2.4 million in 2025, then plunged by 206.45% to -$7.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$7.3 million (Q1 2026), -$2.4 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.